Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
257.85
+4.83 (1.91%)
At close: Dec 5, 2025, 4:00 PM EST
257.99
+0.14 (0.05%)
After-hours: Dec 5, 2025, 7:56 PM EST
Humana Market Cap
Humana has a market cap or net worth of $31.01 billion as of December 5, 2025. Its market cap has decreased by -7.28% in one year.
Market Cap
31.01B
Enterprise Value
38.57B
1-Year Change
-7.28%
Ranking
Category
Stock Price
$257.85
Market Cap Chart
Since December 1, 1998, Humana's market cap has increased from $3.36B to $31.01B, an increase of 823.62%. That is a compound annual growth rate of 8.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 31.01B | 1.51% |
| Dec 31, 2024 | 30.55B | -45.80% |
| Dec 29, 2023 | 56.36B | -13.08% |
| Dec 30, 2022 | 64.84B | 8.76% |
| Dec 31, 2021 | 59.62B | 9.81% |
| Dec 31, 2020 | 54.30B | 11.87% |
| Dec 31, 2019 | 48.54B | 23.50% |
| Dec 31, 2018 | 39.30B | 10.90% |
| Dec 29, 2017 | 35.44B | 16.50% |
| Dec 30, 2016 | 30.42B | 14.97% |
| Dec 31, 2015 | 26.46B | 20.14% |
| Dec 31, 2014 | 22.02B | 36.85% |
| Dec 31, 2013 | 16.09B | 48.20% |
| Dec 31, 2012 | 10.86B | -24.19% |
| Dec 30, 2011 | 14.32B | 55.47% |
| Dec 31, 2010 | 9.21B | 23.61% |
| Dec 31, 2009 | 7.45B | 18.51% |
| Dec 31, 2008 | 6.29B | -50.71% |
| Dec 31, 2007 | 12.76B | 38.78% |
| Dec 29, 2006 | 9.19B | 3.96% |
| Dec 30, 2005 | 8.84B | 86.87% |
| Dec 31, 2004 | 4.73B | 28.57% |
| Dec 31, 2003 | 3.68B | 122.75% |
| Dec 31, 2002 | 1.65B | -16.91% |
| Dec 31, 2001 | 1.99B | -22.25% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |